Inhibition of decidual IGF-1 signaling in response to hypoxia and leucine deprivation is mediated by mTOR and AAR pathways and increased IGFBP-1 phosphorylation.


Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
15 07 2020
Historique:
received: 15 01 2020
revised: 10 05 2020
accepted: 10 05 2020
pubmed: 6 6 2020
medline: 28 5 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Decidual mechanistic target of rapamycin (mTOR) is inhibited, amino acid response (AAR) and protein kinase CK2 are activated, and IGF (insulin-like growth factor) binding protein (IGFBP)-1 is hyperphosphorylated in human intrauterine growth restriction (IUGR). Using decidualized human immortalized endometrial stromal cells (HIESC), we hypothesized that hypoxia and leucine deprivation causing inhibition of decidual IGF-1 signaling is mediated by mTOR, AAR, CK2 and IGFBP-1 phosphorylation. Mass spectrometry demonstrated that hypoxia (1% O

Identifiants

pubmed: 32502935
pii: S0303-7207(20)30165-9
doi: 10.1016/j.mce.2020.110865
pii:
doi:

Substances chimiques

Amino Acid Transport Systems 0
IGFBP1 protein, human 0
Insulin-Like Growth Factor Binding Protein 1 0
Receptors, Amino Acid 0
MTOR protein, human EC 2.7.1.1
Casein Kinase II EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1
Leucine GMW67QNF9C
Sirolimus W36ZG6FT64

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110865

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD089980
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no conflicts of interest related to this work.

Auteurs

Majida Abu Shehab (M)

Department of Pediatrics, University of Western Ontario, London, ON, Canada.

Kyle Biggar (K)

Department of Biology and Institute of Biochemistry, Carleton University, Ottawa, ON, Canada. Electronic address: kyle_biggar@carleton.ca.

Jenica H Kakadia (JH)

Department of Biochemistry, University of Western Ontario, London, ON, Canada.

Manthan Dhruv (M)

Department of Biochemistry, University of Western Ontario, London, ON, Canada.

Bhawani Jain (B)

Department of Biochemistry, University of Western Ontario, London, ON, Canada.

Pinki Nandi (P)

Department of Pediatrics, University of Western Ontario, London, ON, Canada.

Karen Nygard (K)

Biotron Integrated Microscopy Facility, University of Western Ontario, London, ON, Canada.

Thomas Jansson (T)

Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Madhulika B Gupta (MB)

Department of Pediatrics, University of Western Ontario, London, ON, Canada; Department of Biochemistry, University of Western Ontario, London, ON, Canada; Children's Health Research Institute, London, ON, Canada. Electronic address: mbgupta@uwo.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH